Hawkes Pharmacy 2007 Limited 06263665 false 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is that of a retail pharmacy. Digita Accounts Production Advanced 6.30.9574.0 true true 06263665 2022-04-01 2023-03-31 06263665 2023-03-31 06263665 core:AcceleratedTaxDepreciationDeferredTax 2023-03-31 06263665 core:RetainedEarningsAccumulatedLosses 2023-03-31 06263665 core:ShareCapital 2023-03-31 06263665 core:FinancialAssetsCostLessImpairment 2023-03-31 06263665 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 06263665 core:Goodwill 2023-03-31 06263665 core:BetweenTwoFiveYears 2023-03-31 06263665 core:MoreThanFiveYears 2023-03-31 06263665 core:WithinOneYear 2023-03-31 06263665 core:FurnitureFittingsToolsEquipment 2023-03-31 06263665 bus:SmallEntities 2022-04-01 2023-03-31 06263665 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 06263665 bus:FullAccounts 2022-04-01 2023-03-31 06263665 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 06263665 bus:RegisteredOffice 2022-04-01 2023-03-31 06263665 bus:Director1 2022-04-01 2023-03-31 06263665 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 06263665 core:Goodwill 2022-04-01 2023-03-31 06263665 core:ComputerEquipment 2022-04-01 2023-03-31 06263665 core:FurnitureFittings 2022-04-01 2023-03-31 06263665 core:FurnitureFittingsToolsEquipment 2022-04-01 2023-03-31 06263665 core:KeyManagementPersonnel 2022-04-01 2023-03-31 06263665 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-04-01 2023-03-31 06263665 countries:EnglandWales 2022-04-01 2023-03-31 06263665 2022-03-31 06263665 core:Goodwill 2022-03-31 06263665 core:FurnitureFittingsToolsEquipment 2022-03-31 06263665 2021-04-01 2022-03-31 06263665 2022-03-31 06263665 core:AcceleratedTaxDepreciationDeferredTax 2022-03-31 06263665 core:RetainedEarningsAccumulatedLosses 2022-03-31 06263665 core:ShareCapital 2022-03-31 06263665 core:FinancialAssetsCostLessImpairment 2022-03-31 06263665 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 06263665 core:Goodwill 2022-03-31 06263665 core:BetweenTwoFiveYears 2022-03-31 06263665 core:MoreThanFiveYears 2022-03-31 06263665 core:WithinOneYear 2022-03-31 06263665 core:FurnitureFittingsToolsEquipment 2022-03-31 iso4217:GBP xbrli:pure

Registration number: 06263665

Prepared for the registrar

Hawkes Pharmacy 2007 Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2023

 

Hawkes Pharmacy 2007 Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 9

 

Hawkes Pharmacy 2007 Limited

Company Information

Director

H Hawkes

Registered office

52 Windermere Road
Cheltenham
Gloucestershire
GL51 3PH

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Hawkes Pharmacy 2007 Limited

(Registration number: 06263665)
Balance Sheet as at 31 March 2023

Note

2023
 £

2022
 £

Fixed assets

 

Intangible assets

4

585,534

634,327

Tangible assets

5

12,322

12,939

Other financial assets

6

450

450

 

598,306

647,716

Current assets

 

Stocks

37,679

45,000

Debtors

7

194,538

171,833

Cash at bank and in hand

 

82,750

102,047

 

314,967

318,880

Creditors: Amounts falling due within one year

8

(179,742)

(182,948)

Net current assets

 

135,225

135,932

Total assets less current liabilities

 

733,531

783,648

Deferred tax liabilities

(3,081)

(3,235)

Net assets

 

730,450

780,413

Capital and reserves

 

Called up share capital

1,000

1,000

Profit and loss account

729,450

779,413

Total equity

 

730,450

780,413

For the financial year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 28 June 2023
 


H Hawkes
Director

 

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2023

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
52 Windermere Road
Cheltenham
Gloucestershire
GL51 3PH

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

 

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2023

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

15% reducing balance basis

Computer equipment

33.3% reducing balance basis

Goodwill

Goodwill is amortised over its useful life, estimated by the directors to be 20 years.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2023

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2023

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was as follows:

 

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2023

 

4

Intangible assets

Goodwill
 £

Total
£

Cost

At 1 April 2022

975,885

975,885

At 31 March 2023

975,885

975,885

Amortisation

At 1 April 2022

341,557

341,557

Amortisation charge

48,794

48,794

At 31 March 2023

390,351

390,351

Carrying amount

At 31 March 2023

585,534

585,534

At 31 March 2022

634,327

634,327

 

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost

At 1 April 2022

64,372

64,372

Additions

3,077

3,077

At 31 March 2023

67,449

67,449

Depreciation

At 1 April 2022

51,433

51,433

Charge for the year

3,694

3,694

At 31 March 2023

55,127

55,127

Carrying amount

At 31 March 2023

12,322

12,322

At 31 March 2022

12,939

12,939

 

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2023

 

6

Other financial assets (current and non-current)

Financial assets at cost less impairment
£

Total
£

Non-current financial assets

Cost or valuation

At 1 April 2022

450

450

At 31 March 2023

450

450

Carrying amount

At 31 March 2023

450

450

At 31 March 2022

450

450

 

7

Debtors

2023
 £

2022
 £

Trade debtors

157,521

132,630

Other debtors

12,834

14,978

VAT repayable

22,029

22,071

Prepayments

2,154

2,154

 

194,538

171,833

 

8

Creditors

Note

2023
 £

2022
 £

Due within one year

 

Director 's loan account

11

936

624

Trade creditors

 

136,659

133,719

Social security and other taxes

 

32,457

39,380

Accrued expenses

 

9,690

9,225

 

179,742

182,948

 

Hawkes Pharmacy 2007 Limited

Notes to the Financial Statements for the Year Ended 31 March 2023

 

9

Deferred tax

Deferred tax assets and liabilities

2023

Liability
£

Capital allowances in excess of depreciation

3,081

3,081

2022

Liability
£

Capital allowances in excess of depreciation

3,235

3,235

 

10

Financial commitments

Operating leases

The total of future minimum lease payments is as follows:

2023
 £

2022
 £

Not later than one year

6,635

6,635

Later than one year and not later than five years

26,540

26,540

Later than five years

53,080

59,715

86,255

92,890

The amount of non-cancellable operating lease payments recognised as an expense during the year was £6,635 (2022 - £6,259).

 

11

Related party transactions

Key management personnel
The key management personnel is the director of the company.

Summary of transactions with key management

As at 31 March 2023 the company owed H Hawkes, director £936 (2022 - £624). There are no fixed repayment terms and no interest is charged on the loan.